Announcements Trials
Browse Landscape

Phase

Phase 2 8Phase 3 2Phase NA 1Phase 4 1

Status

Unknown 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Multiple Myeloma 3Recurrence 1Neoplasms, Plasma Cell 1Myelodysplastic Syndromes 1Motor Activity 1Leukemia, Myeloid, Acute 1Leukemia 1Hematologic Diseases 1Graft vs Host Disease 1Carcinoma, Hepatocellular 1

Interventions

Radiotherapy 10fludarabine phosphate 9Peripheral Blood Stem Cell Transplantation 8Cyclosporine 7Cyclophosphamide 7Busulfan 7Whole-Body Irradiation 6Melphalan 6Radiofrequency Ablation 5Mycophenolic Acid 5Filgrastim 5Antilymphocyte Serum 5Surveys and Questionnaires 4Surgical Procedures, Operative 4Methotrexate 4Etoposide 4Drug Therapy 4Cisplatin 4fludarabine 3Radiosurgery 3Injections 3Hepatectomy 3Cord Blood Stem Cell Transplantation 3thymoglobulin 2lenvatinib 2Vinblastine 2Videotape Recording 2Thiotepa 2Standard of Care 2Sorafenib 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase NA × Recurrence × Thalidomide × Clear all
NCT01924624 2013-08-16

Adjuvant Therapy With Thalidomide After Curative Resection of Hepatocellular Carcinoma

The First Affiliated Hospital of Xiamen University

Phase NA Unknown
140 enrolled
Gastrointestinal

Carcinoma, Hepatocellular, Recurrence

Data powered by HemOnc (CC BY 4.0) Colophon âš¡